Keyword

larotrectinib

Description: An anticancer tyrosine kinase inhibitor that targets TRK proteins and is used to treat cancers with NTRK gene fusions.
Wikidata ID: wiki/Q27081513
OpenAlex ID: keywords/larotrectinib
2018 · Alexander Drilon, Theodore W. Laetsch, et al. · New England Journal of Medicine · 3,164
2018 · Emiliano Cocco, Maurizio Scaltriti, et al. · Nature Reviews Clinical Oncology · 1,600
2019 · James P. Solomon, Irina Linkov, et al. · Modern Pathology · 582
2019 · Christopher Nevala-Plagemann, Manuel Hidalgo, et al. · Nature Reviews Clinical Oncology · 427
2019 · Maria E Cabanillas, Mabel Ryder, et al. · Endocrine Reviews · 379
2020 · Davendra P.S. Sohal, Erin B. Kennedy, et al. · Journal of Clinical Oncology · 350
2019 · A. Drilon · Annals of Oncology · 316
2019 · J.P. Solomon, R. Benayed, et al. · Annals of Oncology · 292
2019 · Lesley J. Scott · Drugs · 253
2019 · Emiliano Cocco, Alison M. Schram, et al. · Nature Medicine · 236
2021 · François Doz, Cornelis M van Tilburg, et al. · Neuro-Oncology · 201
2022 · Steven G Waguespack, Alexander Drilon, et al. · European Journal of Endocrinology · 198
2019 · Frédérique Penault-Llorca, Erin R Rudzinski, et al. · Journal of Clinical Pathology · 179
2018 · Ed S. Kheder, David S. Hong · Clinical Cancer Research · 175
2022 · Lillian R. Klug, Homma M. Khosroyani, et al. · Nature Reviews Clinical Oncology · 164
2021 · Young Ah Lee, Hyunjung Lee, et al. · Journal of Clinical Investigation · 159
2018 · Li Yan, Wei Zhang · 癌症:英文版 · 132
2022 · Alexander Drilon, Daniel S. W. Tan, et al. · JCO Precision Oncology · 123
2017 · Miho J. Fuse, Koutaroh Okada, et al. · Molecular Cancer Therapeutics · 122
Works count: 1,031
Citation count: 21,000
Year
Topic
Type